Effect of cannabis and subproducts on anthropometric measures: a systematic review and meta-analysis
Authors' conclusion
These findings suggest that cannabis and subproducts could be considered adjuncts in obesity treatment by helping to reduce relevant anthropometric measurements.
Study context
- Population
- RCTs evaluating cannabis and/or subproducts use and changes in anthropometric measures; MEDLINE, Embase, Cochrane Library and Web of Science searched until March 2023
- Comparison
- Cannabis and/or subproducts use vs control
- Outcome
- Changes in body weight, BMI and waist circumference (WC)
Methodological detailsSystematic search of MEDLINE, Embase, Cochrane Library and Web of Science until March 2023; meta-analysis in R software
- Systematic search of MEDLINE, Embase, Cochrane Library and Web of Science until March 2023; meta-analysis in R software
Pooled result
As reported in the abstract
CannabisMean difference (95% CI)
WC
−2.19(−4.44 to 0.06)
- Weight reduced with cannabis
- weight reduction 1.87 kg (95% CI −3.71 to −0.03)
Further pooled results
Body mass index (BMI), subgroup with longer follow-up
- Longer follow-up associated with more pronounced BMI reduction (MD)
- −1.10 (95% CI: −2.23 to 0.03)
- Subgroup analysis
Body fat, cannabinoid CB1
- Cannabinoid CB1 exhibited an increase in body fat (MD)
- 1.70 (95% CI: 0.66-2.74)
Original publication
Effect of cannabis and subproducts on anthropometric measures: a systematic review and meta-analysis. Int J Obes (Lond). Published 7 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →